title: Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells.
abstract: Recent studies in HER-2/neu-targeted immunotherapy demonstrated that polymorphonuclear neutrophils (PMN) mediated Ab-dependent cellular cytotoxicity against HER-2/neu-positive breast cancer cell lines. However, the mechanism of cell death remained unclear. We used several assays to analyze the induction of apoptosis in the breast cancer cell line SK-BR-3 via PMN-dependent Ab-dependent cellular cytotoxicity. In the presence of the HER-2/neu Ab 520C9 and PMN from healthy donors, apoptosis occurred as detected by annexin V binding and disappearance of euploid SK-BR-3 nuclei, which can be differentiated from PMN nuclei by their increased DNA contents. Apoptosis induction was observed with E:T cell ratios as low as 10:1. Laser scanning fluorescence microscopy of TUNEL tumor cells or staining for cleaved cytokeratin-18 further confirmed apoptosis of the SK-BR-3 breast cancer cells. Killing via 520C9 was dependent on the interaction with FcR on PMN, because 1) F(ab')(2) fragments of 520C9 mediated no cytotoxicity, 2) target cell death was influenced by a biallelic polymorphism of FcgammaRIIa on the effector cells, and 3) a bispecific Ab against HER-2/neu and the IgA receptor (FcalphaRI) expressed on effector cells significantly induced apoptosis. Thus, PMN induce Ab-dependent apoptosis against human breast cancer cells targeted with HER-2/neu-directed mAbs or FcR directed bispecific Abs.
authors: Department of Internal Medicine III, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. Bernhard.Stockmeyer@med3.imed.uni-erlangen.de
authors: Bernhard
authors: B
authors: Stockmeyer
authors: Thomas
authors: T
authors: Beyer
authors: Winfried
authors: W
authors: Neuhuber
authors: Roland
authors: R
authors: Repp
authors: Joachim R
authors: JR
authors: Kalden
authors: Thomas
authors: T
authors: Valerius
authors: Martin
authors: M
authors: Herrmann
mesh_terms: D000483:Alleles; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000920:Antibody-Dependent Cell Cytotoxicity / Q000276:immunology*; D017209:Apoptosis / Q000276:immunology*; D001943:Breast Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D002860:Chromium Radioisotopes / Q000378:metabolism; D018920:Coculture Techniques; D003601:Cytotoxicity Tests, Immunologic; D004273:DNA, Neoplasm / Q000378:metabolism; D004306:Dose-Response Relationship, Immunologic; D015536:Down-Regulation / Q000276:immunology; D016193:G1 Phase / Q000276:immunology; D006720:Homozygote; D006801:Humans; D006868:Hydrolysis; D007074:Immunoglobulin G / Q000494:pharmacology; D020287:In Situ Nick-End Labeling; D007633:Keratins / Q000378:metabolism; D007958:Leukocyte Count; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D002860:Chromium Radioisotopes; D004273:DNA, Neoplasm; D007074:Immunoglobulin G; D007633:Keratins